Tag: Covid-19 test

Vistara following a cautious approach in COVID-19 test reports

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Full-service carrier Vistara is adopting a cautious approach in COVID-19 test reports of international passengers after instances of positive testing at arrival following negative reports in India.

Recently, Hong Kong had banned Air India and Vistara from October 17 till October 30 after a few passengers on their flights tested positive for COVID-19 post-arrival.

As per Hong Kong regulation, an airline is barred from operating flights from the origin city for 14 days in case five or more passengers test positive.

Also read: Airlines can operate maximum 60% of pre-COVID domestic flights till Feb 24: Govt

Doubtful about the “behavior of the virus,” Vistara investigated the matter and has found the test reports conducted in India as genuine, chief commercial officer Vinod Kannan said.

Without naming the labs involved, Kannan said the airline is adopting a cautious approach for test reports done by the labs involved and is asking for recertification of test results in such cases.

The airline reiterated that it is following the Indian Council of Medical Research (ICMR) guidelines and is keeping its travel agents informed on the same.

Also read: Vistara expecting to operate all pre-COVID domestic flights by April 2021: CCO

Vistara, which recently started flights to London, remains confident about international flights under air bubbles and is hopeful of full recovery in domestic operations in another 5-6 months.

“We are operating 55-60 percent of pre-COVID capacity so broadly we are at 110-120 flights on a daily basis while we used to operate around 200 daily flights earlier,” Kannan added.

As the travel demand gradually recovers, the joint venture of Singapore Airlines and Tata Sons is not canceling any aircraft order but is rejigging the delivery schedule.

Also read: Indian nationals still restricted entry into some countries: Civil Aviation Minister

Hence, the airline, with 43 aircraft currently in its fleet, has trimmed its fleet target by the end of 2020-21 (Apr-Mar) to 47-48 aircraft from 53 planned earlier.

“It is a combination of real concerns, commercial reasons, operational needs,  and the situation at the manufacturer’s side…,” Kannan added.

India had shut down domestic civil aviation for two months due to the onset of the COVID-19 pandemic and domestic passenger flights resumed from May 25 with capped fares and restricted capacity. The restrictions on fares and capacity have been extended until February 24.

Also read: IndiGo partners with Stemz Healthcare to offer pre-flight COVID-19 tests to passengers

“The most ideal situation for fares is a totally free market…Cognizant of reasons why fare cap is in place, have to play by the rules,” Kannan said.

The Gurugram-based airline has a fleet of 43 aircraft, including 33 Airbus A320, two Airbus A321neo, six Boeing 737-800NG, and two Boeing 787-9 Dreamliner aircraft.

As per September data from the Directorate General of Civil Aviation (DGCA), the airline’s passenger load factor stood at 66.7 percent and its market share in domestic air traffic was at 6.6 percent.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

US Presidential Elections 2020: Trump tests negative for COVID-19, resumes campaigning in Florida

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

President Donald Trump has tested negative for COVID-19 on consecutive days and is not infectious to others, the White House physician said on Monday, as Trump headed to Florida for his first campaign rally since he disclosed he contracted the virus.

Trump’s evening rally at an airport in Sanford, Florida, will kick off a three-week sprint to Election Day as new polls show him losing more ground to Democratic rival Joe Biden in two battleground states that could decide the Nov. 3 contest.

The president’s negative COVID-19 tests were the first announced by the White House since Trump, who spent three days in a military hospital, said on Oct. 2 that he contracted the virus. In a memo, Dr. Sean Conley said the tests and other clinical and laboratory data ”indicate a lack of detectable viral replication.”

Biden also tested negative for COVID-19 on Monday, his campaign said in a statement. The former vice president has tested negative a number of times since Trump announced his positive test.

Trump, 74, is seeking to change the dynamics of a race that national opinion polls and some state polls show he is losing to Biden, who is 77.

Biden pulled further ahead in Wisconsin and Pennsylvania, building momentum in two states that Trump carried in the 2016 presidential election, Reuters/Ipsos opinion polls showed on Monday.

The polls, conducted Tuesday through Sunday, showed Biden now leading Trump by 7 percentage points in both states.

Taking advantage of his momentum and growing advantage in the polls, Biden on Monday campaigned in Ohio, where he was once considered a long shot, as he tries to expand his reach into Republican-leaning states.

Speaking to unionized auto workers in Toledo, Biden said he and former President Barack Obama played a key role in keeping the U.S. auto industry afloat during the financial crisis and recession more than a decade ago.

”Barack and I bet on you and the American worker and it paid off,” said Biden, who is hoping to undermine what polls show is Trump’s greatest strength, the view among some voters that the former real estate entrepreneur is better at handling the economy.

Biden also appeared at a get-out-the-vote event in Cincinnati. It was Biden’s second campaign trip in as many weeks to Ohio, which was once thought out of reach but where polls now show a competitive race.

Trump won the state by 8 percentage points four years ago and almost certainly must carry it again to win re-election. No Republican has won the White House without carrying Ohio.

For months, Trump had worked furiously to shift public attention away from the virus and his handling of the pandemic, which has infected more than 7.8 million people in the United States, killed more than 214,000 and put millions out of work.

His own illness has put the spotlight squarely on his coronavirus response during the closing stretch of the race, with the Biden campaign scaling up its attacks and stretching its campaign into states that normally lean Republican.

FLORIDA UP FOR GRABS

Trump’s rally in Florida, and planned rallies in Pennsylvania on Tuesday, Iowa on Wednesday and North Carolina on Thursday, will be watched closely to see whether the president has reshaped his campaign approach since contracting the virus. ”He has been like a racehorse who has been kept in a starting gate for too long,” Trump campaign senior adviser Steve Cortes told Fox News. ”That horse is ready to gallop.”

Most recent polls in Florida, where a Trump loss would dramatically narrow his path to re-election, show Biden with a small lead. Trump won Florida in 2016 by just 1.2 percentage points.

Critics fault Trump for failing to encourage supporters at campaign events, and even White House staff, to wear protective masks and abide by social-distancing guidelines. At least 11 close Trump aides have tested positive for the coronavirus.

Trump told Fox News on Sunday he felt good and, without producing evidence, that he was now immune, an assertion that drew a flag from Twitter for violating the social media platform’s rules about misleading information related to COVID-19.

The scientific research has been inconclusive on how long people who have recovered from COVID-19 have antibodies and are protected from a second infection.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Positive about flying? Airlines look to COVID tests that give results in minutes

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

European airlines are pinning hopes on pre-flight COVID-19 tests that deliver results as fast as pregnancy tests to help restore passengers’ confidence in taking to the skies in confined spaces with shared air. Germany’s Lufthansa, at the mercy of government bailouts for survival, is in talks with Swiss drugmaker Roche over deploying so-called antigen tests, according to two people familiar with the discussions, as the airline aims to make them available next month.

Italian operator Alitalia, meanwhile, told Reuters that from Wednesday it would add two flights from Milan to Rome, to the two it is already offering from Rome to Milan, exclusively for passengers with negative tests. The tests are administered by health authorities at the airports and included in ticket prices. If they prove popular and safe, these antigen-tested flights will be expanded to more domestic, and later international, routes, the airline said.

Unlike laboratory-based molecular tests that have been the staple of health authorities in the pandemic, antigen tests do not require machines to process. Much like pregnancy tests, they can produce results in about 15 minutes.

However the tests require an uncomfortable nasal swab and are not as accurate as the molecular, or PCR, tests. They generally produce more ”false negatives” which could mean sick people could slip through the cracks and onto planes.

An increasing number are hitting the market, from companies such as Abbott Laboratories, Becton Dickinson & Co and Quidel Corp and Roche, which is rebranding antigen tests from South Korea’s privately held SD Biosensor.

Airlines are pressing governments to embrace alternatives to blanket travel restrictions amid a resurgence of COVID-19 cases in Europe.

Rapid antigen tests that can be administered by non-medical staff are expected to become available in coming weeks for as little as USD 7 each, the head of industry body the International Air Transport Association said on Tuesday.

NEGATIVE-ONLY FLIGHTS

Despite the drawbacks of such antigen tests, carriers hope they could tip the balance in convincing people to fly. ”It is to give … confidence, at a specific point in time, that the result is positive or negative,” said Christian Paulus, a Roche research and development manager.

”The PCR remains the gold standard. Therefore if there are any questions open, or if the clinical appearance of the person who had a negative test, if the person has symptoms like a fever, then you would for sure do confirmatory testing.”

Alitalia launched its ”COVID Tested Flights” programme from Rome to Milan last week, and will expand it from Wednesday. Only passengers with negative COVID-19 results can board.

”So far no positive passengers have been found,” said an Alitalia spokesman, adding that many chose to take the airline’s antigen tests the night before the flight. Travellers can access airport-testing facilities via a preferred lane with their tickets.

The airline plans to analyse findings around the middle of October, but already expects antigen-tested flights will be expanded to domestic and later international routes. ”First, we have to see how this experiment goes,” the spokesman said.

The pre-flight antigen tests follow a scheme in Italy where such tests were used defensively. SD Biosensor said its tests had been deployed at Italian airports for incoming tourists, to avoid a renewed COVID-19 wave imported from infection hotspots.

’BETTER THAN QUARANTINE’

Lufthansa Chief Executive Carsten Spohr last week told employees during a townhall meeting that the airline was in talks with Roche. The drugmaker started selling the rapid tests this week, and said SD Biosensor could initially supply it with about 40 million tests per month.

The Lufthansa tests could initially go to cabin crews, a spokeswoman said, though Bjoern Becker, a senior director of product management, ground & digital services for the Lufthansa Group, said the tests could also be made available to first-class and business-class passengers.

”We think the tests would be a better option than putting somebody into quarantine,” the airline spokeswoman said. Beyond airlines, Germany is eyeing broader antigen test use from October, including in nursing homes where older patients have been hardest hit by the deadly virus.

Regulators still worry about test accuracy, which typically detect the virus 80 percent to 90 percent of the time, below the 95 percent rate of lab tests. Still, some officials don’t want the perfect to be the enemy of the pretty good as they pursue some semblance of economic normality.

”They’re good enough,” German health minister Jens Spahn said, pledging antigen tests in ”significant quantities”. The state of Bavaria has already ordered 10 million.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

IPL 2020: 8 different hotels for teams, mandatory COVID test before flying to the UAE; here’s SOP

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Eight different hotels for the eight participating teams, two mandatory negative COVID-19 test reports before flying to the UAE and punishment for any breach of the bio-secure protocol are part of the BCCI’s SOP for the IPL that was handed over to the franchises on Wednesday.

The document, accessed by PTI, states that every franchisee’s medical team should obtain the “medical and travel history of all players and support staff” since March 1 this year.

“All Indian players and team support staff must undergo two COVID-19 PCR tests, 24 hours apart, in the week before assembling in the franchises’ city of choice,” it states.

“This will help reduce the risk of cross infection within the group before flying to the UAE.

“Breach of any Bio-Secure Environment protocols by players and team support staff will be punishable under the IPL Code of Conduct Rules.”

Anyone testing positive for COVID-19 will be quarantined and after completion of a 14-day period, the individual will have to undergo two COVID-19 tests, 24 hours apart.

“…if both test reports are negative, he/she may be allowed to fly out to the UAE.”

The rule will apply to all the overseas players and team support staff as well.

“After arrival in UAE, there will be tests on Day 1, 3 and 6 with testing every fifth day throughout the tournament.”

The SOP states that all “franchise teams will be put up in different hotels.”

“Team members must be allotted rooms in a separate wing of the hotel that has a separate centralised air conditioning (AC) unit than the rest of the hotel,” it adds.

“After the third negative test, team members may be allowed to meet each other within the Bio-Secure Environment. However, wearing a face mask and social distancing protocols must be followed at all times.”

The SOP also requires teams to order food in individual rooms and avoid use of common dining areas “to prevent cross infection and coming in contact with other hotel guests.”

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Scientists identify alternative technique that could speed up COVID-19 testing

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Scientists have identified an alternative amplification technique to detect the genetic material of SARS-CoV-2, that causes COVID-19, which could offer a way to rapidly test large number of people for the disease.

However, the researchers from Heidelberg University in Germany noted that the technique is not as sensitive as quantitative RT-PCR, the current standard method for COVID-19 testing.

Faster and less complicated testing could aid in the rapid isolation of infected people and help to identify and prevent new outbreaks of the disease until a vaccine becomes available, they said.

The researchers noted that quantitative RT-PCR can successfully detect viral RNA but requires expensive machinery and chemical reagents that can sometimes be in short supply.

The standard method also depends on time-consuming temperature cycling steps to amplify enough RNA from a patient sample for detection, resulting in a processing time between three and 24 hours in most clinical laboratories, they said.

In the journal Science Translational Medicine, the researchers propose using a technique called reverse transcription loop-mediated isothermal amplification (RT-LAMP), which can be carried out at a constant temperature using simple equipment and a different set of reagents.

In their tests of RNA isolated from 768 nasopharyngeal swabs from individuals tested for COVID-19, the researchers determined that RT-LAMP was less sensitive than quantitative RT-PCR but could be used to evaluate large groups of people, with an average test processing times of 30 minutes.

They concluded that RT-LAMP works best for identifying people with moderate to high amounts of SARS-CoV-2 virus in their bodies, but is not sensitive enough to identify infection in people with a low viral load — such as those at the beginning or end of the illness.

The researchers also tested the possibility of using RT-LAMP directly on nasopharyngeal swabs — without the need for RNA isolation — but concluded this technique was less sensitive than using isolated RNA.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Doctor’s prescription not compulsory for COVID-19 tests in Mumbai

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Bhihanmumbai Municipal Corporation (BMC) has allowed people from Mumbai to get themselves tested for COVID-19 without a doctor’s prescription. Till now it was compulsory to have a doctor’s prescription for getting tested for COVID-19.

Earlier today Aditya Thackrey, Maharashtra’s Cabinet Minister confirmed the development by tweeting ‘BMC has decided to open up testing to any individual in the city without prescription/self attestation. Labs can now conduct RT PCR tests as per ICMR guidelines at the will of anyone. This will help citizens feel safer and test when they have a doubt, without any delays’.

BMC’s move to allow COVID-19 tests without doctor’s prescription will make it easier for people of Mumbai to get themselves tested without wasting any time.

As per the state Health Department the number of COVID-19 cases in Maharashtra spiked by 5,134 on Tuesday, taking the total count to 2,17,121. With 224 more patients succumbing to the infection, the death toll has gone up to 9,250. A total of 3,296 patients were discharged from hospitals on Tuesday, taking the number of the recovered cases to 1,18,558. The number of active cases in the state now stands at 89,294.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Corona symptoms: Govt mulls to include sudden loss of taste, smell as criteria for COVID-19 test

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

The government is mulling to include sudden loss of taste and smell as a criteria for COVID-19 testing, sources said on Friday as India witnessed a surge in coronavirus instances with total caseload racing towards the three lakh mark.

The issue was discussed in a meeting of the National Task Force on COVID-19 held last Sunday, but no consensus on the matter has been reached yet.

“At the meeting, some members suggested including loss of taste and smell in the eligibility criteria for COVID-19 testing stating that several patients have been reporting symptoms like these,” a source in the health ministry said.

According to an expert, even though the symptom is not specific to COVID-19 as one may suffer from loss of smell and taste when they have flu or influenza, it could be one of the early signs of the onset of the disease and prompt detection may help in early treatment.

The US’ national public health institute the Centres for Disease Control and Prevention (CDC) had in early May incorporated “a new loss of taste or smell” in the list of COVID-19 symptoms.

According to the Indian Council of Medical Research’s revised testing strategy for COVID-19 issued on May 18, all returnees and migrants with symptoms of influenza-like illness (ILI) are to be tested within seven days of the onset of the trails.

All hospitalised patients who develop ILI symptoms and frontline workers involved in containment and mitigation of COVID-19 having such symptoms will also be tested for COVID-19 through the RT-PCR test, it said, adding asymptomatic direct and high-risk contacts of a confirmed case has to be tested once between day five and 10 of coming in contact.

Symptomatic ILI patients living in coronavirus hotspots or containment zones, all patients of severe acute respiratory infection (SARI), symptomatic healthcare workers also are eligible for testing as per the guidelines.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

Delhi CM Arvind Kejriwal’s COVID-19 test results negative

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Delhi Chief Minister Arvind Kejriwal’s COVID-19 test results came out negative on Tuesday. The 51-year-old Delhi chief minister and the Aam Aadmi Party (AAP) chief underwent the COVID-19 test earlier in the day after developing sore throat and fever.

The chief minister had gone into self-quarantine after developing mild fever and sore throat. Kejriwal has not been attending any meeting since Sunday afternoon.

Kejriwal is known to have diabetes and other health problems, and doctors had advised him on Monday to wait another day before the test was conducted.

The national capital has reported the third-highest number of coronavirus cases in India at 29,943. Delhi is only behind Maharashtra which has reported the highest COVID-19 cases at 88,528, followed by Tamil Nadu at 33,229.

Delhi has also reported a total of 874 fatalities, the third-highest for any state in India, after Maharashtra’s 3,169 deaths and Gujarat’s 1,280.

As per the Union health ministry updates on Tuesday morning, Delhi added 62 deaths, the second-highest for the day after Maharashtra’s 102.

Overall, India’s death toll due to COVID-19 rose to 7,466 and the number of cases climbed to 2,66,598 in the country after it registered 266 fatalities and a record single-day spike of 9,987 cases till Tuesday 8 am, according to the Union Health Ministry data.

India is the fifth worst-hit nation by the COVID-19 pandemic after the US, Brazil, Russia and the UK, according to the Johns Hopkins University data.

The number of active novel coronavirus cases stands at 1,29,917, while 1,29,214 people have recovered and one patient has migrated, it said.

For all the latest updates and trends on the novel coronavirus outbreak in India, follow CNBC-TV18.com’s blog

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

RML Hospital gives out erroneous COVID test results, violates norms: AAP

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

Aam Aadmi Party’s national spokesperson and MLA from Rajinder Nagar Raghav Chadha on Wednesday slammed the central government-run Ram Manohar Lohia Hospital for giving out erroneous COVID-19 test reports and delaying the results of tests.

Chadha said Delhi government re-tested 30 samples from RML Hospital, which were declared COVID positive; 12 found to be negative and result for 2 was inconclusive.

The hospital is giving 45 percent erroneous result and the Delhi government should take stringent action against them, added Chadha, in a statement.

It is also violating the government’s instruction of submitting test results within 48 hours, he pointed out.

“They delayed results for 3, 4, 7, 10, and even 31 days.”

He said RML Hospital is one of the very famous hospitals in the national capital but unfortunately this institution has been violating the protocols and guidelines of testing laid down by the Centre, Delhi government, Delhi High Court and ICMR.

“As per the protocol and to maintain the certainty of the tests, the Delhi government checks the test results of the hospitals by re-testing some samples time and again. Recently the Delhi government took 30 samples from the RML hospitals which were declared to be positive by the RML and sent for re-testing.”

“You will be surprised to know that the result of 12 samples out of 30 came negative and results for two samples were inconclusive. The rest was done within 24 hours after the samples were declared positive by the RML hospital.”

“This means that there was an error of 45% in RML’s testing. Such a huge variation in result of COVID019 test is unacceptable. Think about the patients’ mental state, their families, neighbours and the trauma they go through when they are found to be positive. Such false and erroneous results are highly condemnable and this exposes the negligence of the RML hospital.” The AAP national spokesperson added.

Chadha also urged the citizens of Delhi to avoid getting treated at RML hospital because this may put them at high risk since the hospital is not following the norms of the governments.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow

SC junks plea seeking mass testing for Covid-19 

KV Prasad Jun 13, 2022, 06:35 AM IST (Published)

Listen to the Article (6 Minutes)

The Supreme Court on Monday declined to entertain a petition seeking direction to the Centre to conduct en masse door to door testing for COVID-19 and challenging the validity of PM CARES fund, and termed it having “political colour.”

A bench headed by Justice NV Ramana and comprising Justices SK Kaul and BR Gavai expressed discontent on the petition and asked the advocate Shashwat Anand to withdraw the petition or the court will impose fine on it. “The petition has political colour. Either you withdraw it or we will slap fine”, said Justice Ramana.

The petitioners had moved the court expressing grave concerns on the strategy deployed by the Centre to fight the outbreak of the coronavirus in the country. The petition argued that India is lagging behind in testing, and cited Indian Council of Medical Research’s (ICMR) status report on April 7, 2020. The petitioners contended Centre is conducting merely 82 tests per million people across the country.

The petition said the most worrying is that the reported confirmed COVID-19 cases, for sure, could be a gross underestimate as the testing rate in India is amongst the lowest in the world. The petitioners argued the spike in the number of corona infected cases within a matter of days, shows that it may only be the tip of the iceberg.

The petition suggested that instead of looking to curb community transmission, emphasis should be laid on managing and treating the virus, and for this, the first step would be mass testing.

“India’s response to fighting this pandemic is basal. It is primarily focused on curbing community transmission, rather than managing, identifying and treating the virus infection following the mass tests which is, to put it differently, evinced by the lack of enough and mass house-to-house tests as proportional to the humongous and densely packed population of India”, said the petition.

Also catch all the latest updates and trends on the novel coronavirus with CNBCTV18’s blog.

Elon Musk forms several ‘X Holdings’ companies to fund potential Twitter buyout

3 Mins Read

Thursday’s filing dispelled some doubts, though Musk still has work to do. He and his advisers will spend the coming days vetting potential investors for the equity portion of his offer, according to people familiar with the matter

KV Prasad Journo follow politics, process in Parliament and US Congress. Former Congressional APSA-Fulbright Fellow